SARS‐CoV‐2 Vaccination and Immune Thrombocytopenia in Children: A Multicenter Study
Pediatric Blood & Cancer · 2026
DOI: 10.1002/1545-5017.70448 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Pediatric Blood & Cancer, 2026. Verfasst von Guarina Angela und 30 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Onco-Hematology Unit, A.R.N.A.S. Civico Hospital, Palermo, Italy. Hauptthemen laut MEDLINE: Purpura, Thrombocytopenic, Idiopathic, COVID-19 Vaccines, COVID-19, Vaccination. Die Arbeit nennt 64 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Immune thrombocytopenia (ITP) is the most common acquired bleeding disorder in childhood. Although viral infections and some vaccinations are recognized triggers, data on the onset or exacerbation of ITP following severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) vaccination in pediatric patients remain limited.
Objectives
To evaluate the incidence and clinical characteristics of new‐onset ITP and the safety of SARS‐CoV‐2 vaccination in children with preexisting or resolved ITP.
Methods
We evaluated the incidence and clinical characteristics of ITP occurring after SARS‐CoV‐2 vaccination, as well as the effects of vaccination in children with preexisting ITP.
Results
De novo ITP: five cases of new‐onset ITP were identified nationwide, most of which occurred after the first vaccine dose (80%). Despite low median platelet counts at presentation, no major or fatal bleeding events were observed. Most patients responded favorably to first‐line treatments (intravenous immunoglobulins and/or corticosteroids), and 80% achieved normal platelet counts at the last follow‐up. Preexisting ITP: among 164 vaccinated patients with complete clinical data, only 8.5% ( n = 14) experienced a transient platelet count decline or new bleeding manifestations. Notably, no relapses occurred among the 34 patients who were in clinical remission at the time of vaccination.
Conclusions
ITP following SARS‐CoV‐2 vaccination in the pediatric population is exceedingly rare and generally mild. Moreover, SARS‐CoV‐2 vaccination appears safe in children with preexisting or resolved ITP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pediatric Onco-Hematology Unit, A.R.N.A.S. Civico Hospital, Palermo, Italy.
- Department of Biomedical Sciences and Human Oncology, University of Bari "Aldo Moro", Bari, Italy.
- Department of Public Health and Pediatric Sciences, Regina Margherita Children's Hospital, University of Turin, Turin, Italy.
- Medical Direction, Children's Hospital, ASST-Spedali Civili, Brescia, Italy.
- Pediatric Onco-Hematology Unit, Children's Hospital, ASST-Spedali Civili, Brescia, Italy.
- Hematology Unit, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
Zitieren
APA
Angela, G., Paola, G., Giuseppe, L., Ugo, R., Paola, S., Loredana, F., Sabrina, B., Sofia, T., Dora, N. L., Chiara, G., Maurizio, M., Erika, M., Barbara, B., Irene, D., Angelica, B., Ilaria, F., Giuseppe, P., Gianluca, B., Federico, V., …, & Piero, F. (2026). SARS‐CoV‐2 Vaccination and Immune Thrombocytopenia in Children: A Multicenter Study. Pediatric Blood & Cancer. https://doi.org/10.1002/1545-5017.70448
Vancouver
Angela G, Paola G, Giuseppe L, Ugo R, Paola S, Loredana F, et al. SARS‐CoV‐2 Vaccination and Immune Thrombocytopenia in Children: A Multicenter Study. Pediatric Blood & Cancer. 2026. doi:10.1002/1545-5017.70448
BibTeX
@article{Angela2026,
author = {Angela, Guarina and Paola, Giordano and Giuseppe, Lassandro and Ugo, Ramenghi and Paola, Saracco and Loredana, Farinasso and Sabrina, Bombaci and Sofia, Tasca and Dora, Notarangelo Lucia and Chiara, Gorio and Maurizio, Miano and Erika, Massaccesi and Barbara, Bruschi and Irene, D'Alba and Angelica, Barone and Ilaria, Fontanili and Giuseppe, Palumbo and Gianluca, Boscarol and Federico, Verzegnassi and Simone, Cesaro and Agnese, Corbelli and Silverio, Perrotta and Maddalena, Casale and Francesca, Rossi and Mariamaddalena, Marrapodi and Antonio, Ruggiero and Alberto, Romano and Saverio, Ladogana and Angela, Maggio and Giovanna, Russo and Piero, Farruggia},
title = {SARS‐CoV‐2 Vaccination and Immune Thrombocytopenia in Children: A Multicenter Study},
journal = {Pediatric Blood & Cancer},
year = {2026},
doi = {10.1002/1545-5017.70448}
}
EUVIMED